1. ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM). (11th November 2019) Authors: Lassman, Andrew; Pugh, Stephanie; Wang, Tony; Aldape, Kenneth; Gan, Hui; Preusser, Matthias; Vogelbaum, Michael; Sulman, Erik; Won, Minhee; Zhang, Peixin; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; Seidel, Clemens; De... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial. Issue 10274 (13th February 2021) Authors: Sezer, Ahmet; Kilickap, Saadettin; Gümüş, Mahmut; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Turk, Haci M; Cicin, Irfan; Bentsion, Dmitry; Gladkov, Oleg; Clingan, Philip; Sriuranpong, Virote; Rizvi, Naiyer; Gao, Bo; Li, Siyu; Lee, Sue; McGuire, Kristina; Chen, Chieh-I; Makharadze,... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-51. NEUROCOGNITIVE FUNCTION (NCF) OUTCOMES OF RTOG FOUNDATION 3508: A PHASE 3 TRIAL OF ABT-414 WITH CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH EGFR-AMPLIFIED NEWLY DIAGNOSED GBM. (9th November 2020) Authors: Wefel, Jeffrey S; Won, Minhee; Lassman, Andrew; Stern, Yaakov; Wang, Tony; Aldape, Kenneth; Armstrong, Terri; Vogelbaum, Michael; Sulman, Erik; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Gan, Hui; Preusser, Matthias; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; ... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. Issue 2 (15th July 2022) Authors: Lassman, Andrew B; Pugh, Stephanie L; Wang, Tony J C; Aldape, Kenneth; Gan, Hui K; Preusser, Matthias; Vogelbaum, Michael A; Sulman, Erik P; Won, Minhee; Zhang, Peixin; Moazami, Golnaz; Macsai, Marian S; Gilbert, Mark R; Bain, Earle E; Blot, Vincent; Ansell, Peter J; Samanta, Suvajit; Kundu, Mada... Journal: Neuro-oncology Issue: Volume 25:Issue 2(2023) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study. Issue 32 (10th November 2021) Authors: Ramalingam, Suresh S.; Novello, Silvia; Guclu, Salih Zeki; Bentsion, Dmitry; Zvirbule, Zanete; Szilasi, Maria; Bernabe, Reyes; Syrigos, Konstantinos; Byers, Lauren Averett; Clingan, Philip; Bar, Jair; Vokes, Everett E.; Govindan, Ramaswamy; Dunbar, Martin; Ansell, Peter; He, Lei; Huang, Xin; Sehg... Journal: Journal of clinical oncology Issue: Volume 39:Issue 32(2021) Page Start: 3633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗